Janus Henderson Group’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $555K | Hold |
109,728
| – | – | ﹤0.01% | 1895 |
|
|
2025
Q1 | $638K | Buy |
109,728
+26,100
| +31% | +$152K | ﹤0.01% | 1829 |
|
|
2024
Q4 | $565K | Hold |
83,628
| – | – | ﹤0.01% | 1975 |
|
|
2024
Q3 | $552K | Hold |
83,628
| – | – | ﹤0.01% | 1984 |
|
|
2024
Q2 | $626K | Buy |
83,628
+21,206
| +34% | +$159K | ﹤0.01% | 1871 |
|
|
2024
Q1 | $621K | Buy |
62,422
+25
| +0% | +$249 | ﹤0.01% | 1906 |
|
|
2023
Q4 | $614K | Sell |
62,397
-109
| -0.2% | -$1.07K | ﹤0.01% | 1893 |
|
|
2023
Q3 | $478K | Buy |
62,506
+96
| +0.2% | +$735 | ﹤0.01% | 1940 |
|
|
2023
Q2 | $466K | Buy |
62,410
+41,026
| +192% | +$306K | ﹤0.01% | 2017 |
|
|
2023
Q1 | $143K | Buy |
+21,384
| New | +$143K | ﹤0.01% | 2569 |
|
|
2022
Q3 | – | Sell |
-10,162
| Closed | -$83K | – | 2593 |
|
|
2022
Q2 | $83K | Buy |
+10,162
| New | +$83K | ﹤0.01% | 2502 |
|